Amundi Purchases 24,038 Shares of Patterson Companies, Inc. (NASDAQ:PDCO)

Amundi boosted its stake in shares of Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 103.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 47,230 shares of the company's stock after buying an additional 24,038 shares during the quarter. Amundi owned approximately 0.05% of Patterson Companies worth $1,457,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in PDCO. BNP Paribas Financial Markets boosted its position in Patterson Companies by 31.5% during the third quarter. BNP Paribas Financial Markets now owns 33,257 shares of the company's stock worth $726,000 after purchasing an additional 7,969 shares during the period. Goodman Financial Corp boosted its position in Patterson Companies by 19.1% during the third quarter. Goodman Financial Corp now owns 543,282 shares of the company's stock worth $11,865,000 after purchasing an additional 86,972 shares during the period. Mork Capital Management LLC boosted its position in Patterson Companies by 142.9% during the third quarter. Mork Capital Management LLC now owns 84,980 shares of the company's stock worth $1,856,000 after purchasing an additional 50,000 shares during the period. Barclays PLC boosted its position in Patterson Companies by 37.2% during the third quarter. Barclays PLC now owns 165,715 shares of the company's stock worth $3,619,000 after purchasing an additional 44,906 shares during the period. Finally, EMC Capital Management boosted its position in Patterson Companies by 600.7% during the fourth quarter. EMC Capital Management now owns 16,053 shares of the company's stock worth $495,000 after purchasing an additional 13,762 shares during the period. Institutional investors own 85.43% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Piper Sandler cut their target price on shares of Patterson Companies from $26.00 to $24.00 and set a "neutral" rating for the company in a research report on Friday, December 6th. Morgan Stanley increased their target price on shares of Patterson Companies from $27.00 to $31.35 and gave the stock an "equal weight" rating in a research report on Tuesday, December 17th. Leerink Partners restated a "market perform" rating and issued a $31.35 price objective (up from $29.00) on shares of Patterson Companies in a research report on Wednesday, December 11th. Mizuho initiated coverage on shares of Patterson Companies in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $23.00 price objective for the company. Finally, Leerink Partnrs downgraded shares of Patterson Companies from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Eleven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $26.57.

Patterson Companies Price Performance

Shares of PDCO stock traded down $0.03 during trading hours on Friday, hitting $31.16. 2,160,892 shares of the company's stock were exchanged, compared to its average volume of 1,017,098. The company has a market capitalization of $2.76 billion, a PE ratio of 18.22, a PEG ratio of 2.71 and a beta of 0.99. Patterson Companies, Inc. has a 12-month low of $19.45 and a 12-month high of $31.79. The business's 50 day simple moving average is $31.04 and its 200-day simple moving average is $26.17. The company has a current ratio of 1.37, a quick ratio of 0.76 and a debt-to-equity ratio of 0.34.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.